×
For best experience we recommend to activate Javascript in your browser.
CCL19 antibody (AA 22-107)
The Rabbit Polyclonal anti-CCL19 antibody has been validated for WB, IHC, IP and ICC. It is suitable to detect CCL19 in samples from Mouse.
Quick Overview for CCL19 antibody (AA 22-107) (ABIN7621973)
Target
See all CCL19 Antibodies
CCL19
(Chemokine (C-C Motif) Ligand 19 (CCL19))
Reactivity
All reactivities for CCL19 antibodies
Mouse
Host
All hosts for CCL19 antibodies
Rabbit
Clonality
All clonalities for CCL19 antibodies
Polyclonal
Conjugate
All conjugates for CCL19 antibodies
This CCL19 antibody is un-conjugated
Application
All applications for CCL19 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-CCL19 Antibody
(hide)
Binding Specificity
All epitopes for CCL19 antibodies
AA 22-107
Purpose
Macrophage Inflammatory Protein 3 Beta (MIP3b) Polyclonal Antibody
Sequence
Pro22~Val107
Characteristics
The Macrophage Inflammatory Protein 3 Beta (MIP3b) Polyclonal Antibody (Species: Mouse) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for CCL19
(hide)
Target
CCL19
(Chemokine (C-C Motif) Ligand 19 (CCL19))
Alternative Name
MIP3b
Gene ID
24047
UniProt
O70460
Pathways
Positive Regulation of Immune Effector Process
Recently viewed
(hide)
Chat with us , powered by LiveChat